Covidien Initiates Quarterly Cash Dividend



    PEMBROKE, BERMUDA, September 28 /CNW/ - Covidien Ltd. (NYSE:   COV; BSX:
COV) announced today that its Board of Directors has declared a quarterly cash
dividend of $0.16 per common share. The dividend is payable on November 9,
2007 to shareholders of record on October 9, 2007.

    "This declaration, our first dividend as a public company, is an
important milestone for the Company and its investors," said President and
Chief Executive Officer Richard J. Meelia.

    ABOUT COVIDIEN LTD.

    Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines, including
Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions,
Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products,
Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion,
Covidien has more than 43,000 employees worldwide in 57 countries, and its
products are sold in over 130 countries. For additional information, please
visit our website, www.covidien.com.




For further information:

For further information: Covidien Ltd. Eric Kraus, 508-261-8305 Senior
Vice President Corporate Communications eric.kraus@covidien.com or Coleman
Lannum, CFA, 508-452-4343 Vice President Investor Relations
cole.lannum@covidien.com or Bruce Farmer, 508-452-4372 Director Financial
Communications bruce.farmer@covidien.com or Wayde McMillan, 508-452-4387
Director Investor Relations wayde.mcmillan@covidien.com

Organization Profile

COVIDIEN LTD.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890